expressbpdFebruary 12, 2019
Tag: Aurobindo , Apotex , acquisition , Pharma
The company had inked a binding agreement on July 14, 2018
Aurobindo Pharma has completed the EUR 74-million deal to acquire Apotex’s commercial operations and certain supporting infrastructure in five European countries.
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex’ European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.
This announcement does not constitute a recommendation to shareholders or potential investors, it added.
Register as Visitor to CPhI China 2019!
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: